Representative before the EPO

Employment test 51 - 200 employees
Company dna j a kemp
no operation time available
1141.97
Headquarter in London and 4 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

We have observed 46 EP applications Lee Phillip Chapman has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after December 16, 2012). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11721395

METABOLIC BIOMARKERS OF AUTISM

IPC classification:
G01N 33/50
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Lee Phillip Chapman, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP11818848

METHODS OF TREATING MILD COGNITIVE IMPAIRMENT (MCI) AND RELATED DISORDERS

IPC classification:
A01N 43/42, A61K 31/44, A61P 25/28
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12709144

DENDRITIC CELLS OBTAINED FROM INDUCED PLURIPOTENT STEM CELLS (IPSCS)

IPC classification:
C12N 5/074, C12N 5/0784
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12710424

BIOMARKER FOR CORONARY ARTERY DISEASE

IPC classification:
G01N 33/564, G01N 33/68, G01N 33/92
Applicant:
University of Nebraska
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12706308

AAV -VECTORS FOR USE IN GENE THERAPY OF CHOROIDEREMIA

IPC classification:
C12N 9/10, C12N 15/864
Applicant:
Oxford University Innovation Ltd
Agent:
Simon Warwick O'Brien, D Young & Co LLP
Agent:
Lee Phillip Chapman, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12726165

COUPLING METHOD

IPC classification:
B82Y 15/00, G01N 33/487
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12753551

HAIRPIN LOOP METHOD FOR DOUBLE STRAND POLYNUCLEOTIDE SEQUENCING USING TRANSMEMBRANE PORES

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13187149

Enzyme-pore constructs

IPC classification:
C12N 9/12, C12N 9/22, C12N 9/52, C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP13185826

Molecular diagnosis and classification of malignant melanoma

IPC classification:
C12Q 1/68, G01N 33/53, G01N 33/574
Applicant:
University of California
Agent:
Lee Phillip Chapman, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13185817

Molecular diagnosis and classification of malignant melanoma

IPC classification:
G01N 33/53
Applicant:
University of California
Agent:
Lee Phillip Chapman, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13185821

Molecular diagnosis and classification of malignant melanoma

IPC classification:
C12Q 1/68, G01N 33/53, G01N 33/574
Applicant:
University of California
Agent:
Lee Phillip Chapman, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12844836

TRANSGENIC PIG MODELS OF CYSTIC FIBROSIS

IPC classification:
C07H 21/04, G01N 33/15
Applicant:
University of Iowa Research Foundation
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13195156

Reagents and Methods for PCR

IPC classification:
C12Q 1/68
Applicant:
Brandeis University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP12816096

METHOD FOR CHARACTERISING A POLYNUCELOTIDE BY USING A XPD HELICASE

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14171183

Hydrogel comprising cells for local release of growth factors to mediate motor recovery after stroke

IPC classification:
A61K 38/18, A61L 27/38, A61L 27/52, A61P 25/00
Applicant:
BioTime Inc
Applicant:
University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14173519

Selectively targeted antimicrobial peptides and the use thereof

IPC classification:
A01N 37/46, A61K 38/00, C07K 7/00, C07K 7/06, C07K 7/08, C07K 14/00, C07K 14/315
Applicant:
University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13735960

PURIFICATION OF FLAVIVIRUSES

IPC classification:
B01D 15/00, C12N 7/00, C12N 7/02
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13706056

APTAMER METHOD

IPC classification:
G01N 33/487, G01N 33/53, G01N 33/543
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14170690

Targeting complement factor H for treatment of diseases by the sue of CR2-FH molecules

IPC classification:
A61K 38/00, C07K 14/435
Applicant:
The Regents of the University of Colorado
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13718667

COMPOSITIONS AND TREATMENTS BASED ON CADHERIN MODULATION

IPC classification:
A61K 31/7088, A61P 17/02, C12N 15/113
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13711464

MUTANT LYSENIN PORES

IPC classification:
C07K 14/435, C12Q 1/00
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP13784660

METHODS FOR DETERMINING ABSOLUTE GENOME-WIDE COPY NUMBER VARIATIONS OF COMPLEX TUMORS

IPC classification:
C12Q 1/68
Applicant:
Complete Genomics Inc
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14180710

Stabilization of vaccines by lyophilization

IPC classification:
A61K 9/19, A61K 39/00, A61K 39/12, C07K 14/005, C12N 7/00
Applicant:
Sanofi Pasteur Biologics LLC
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP14194551

Antibodies against Clostridium difficile toxins and uses thereof

IPC classification:
A61K 39/08, A61K 39/395, A61K 47/48, A61P 1/00, A61P 1/12, A61P 31/04, C07K 16/12, C12N 1/15, C12N 1/21, C12N 5/10, C12N 15/13
Applicant:
University of Massachusetts
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP12877555

COMPOSITIONS AND METHODS RELATED TO PREVENTION AND TREATMENT OF RABIES INFECTION

IPC classification:
A61K 39/42, A61P 31/14, C07K 16/10, C12N 15/13
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP13740351

ENZYME CONSTRUCT

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13740348

MODIFIED HELICASES

IPC classification:
C12N 9/12, C12N 9/14
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP13742041

SSB METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13830498

A NOVEL POLYMAVIRUS ASSOCIATED WITH DIARRHEA IN CHILDREN

IPC classification:
C07K 14/025, C07K 16/08, C12N 15/37, C12Q 1/68, G01N 33/569
Applicant:
Universidad Nacional Autonoma de Mexico
Applicant:
University of California
Agent:
Lee Phillip Chapman, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP13762540

SAMPLE PREPARATION METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13789619

QUADRUPLEX METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
The patent has been granted
EP13826752

USE OF ERIBULIN IN THE TREATMENT OF BREAST CANCER

IPC classification:
A61K 31/335, A61P 35/00
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14702643

ENZYME STALLING METHOD

IPC classification:
C12Q 1/68, G01N 33/487
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14722013

METHODS AND MATERIALS FOR HEMATOENDOTHELIAL DIFFERENTIATION OF HUMAN PLURIPOTENT STEM CELLS UNDER DEFINED CONDITIONS

IPC classification:
C12N 5/00, C12N 5/071, C12N 5/0775, C12N 5/0789, C12N 5/095
Applicant:
Wisconsin Alumni Research Foundation (WARF)
Agent:
Lee Phillip Chapman, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14724622

NANOPORE BIOSENSORS FOR DETECTION OF PROTEINS AND NUCLEIC ACIDS

IPC classification:
C07K 14/255
Applicant:
Katholieke Universiteit Leuven
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP11822599

CELL CULTURE SCREEN FOR AGENTS THAT CONTROL ADIPOGENESIS AND MYOFIBROBLAST DIFFERENTIATION

IPC classification:
C12N 5/071
Applicant:
University of California
Agent:
Lee Phillip Chapman, J A Kemp
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP15729886

IMMUNO-MODULATORY PROGENITOR (IMP) CELL

IPC classification:
C12N 5/071, C12N 5/078
Agent:
Multiple attorneys, J A Kemp
Status:
PATENT GRANTED
EP15182059

METHOD OF CHARACTERIZING A TARGET POLYNUCLEOTIDE USING A TRANSMEMBRANE PORE AND MOLECULAR MOTOR

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION REQUESTED
EP15181440

KITS FOR ANALYZING SINGLE-STRANDED NUCLEIC ACID SEQUENCES

IPC classification:
C12Q 1/68, G01N 21/76, G01N 33/48
Applicant:
Brandeis University
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14726726

MULTICOLOR FLOW CYTOMETRY METHOD FOR IDENTIFYING A POPULATION OF CELLS, IN PARTICULAR MESENCHYMAL STEM CELLS

IPC classification:
C12N 5/0775, G01N 33/50
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP15194590

HUMAN CYTOMEGALOVIRUS NEUTRALIZING ANTIBODIES AND USE THEREOF

IPC classification:
A61K 38/00, A61K 39/00, A61K 39/42, C07K 14/005, C07K 16/08, C12N 15/13
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14732605

METHOD OF DETECTING THE PRESENCE OR ABSENCE OF AUTOANTIBODIES

IPC classification:
C12N 1/20
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14739971

USE OF ERIBULIN AND LENVATINIB AS COMBINATION THERAPY FOR TREATMENT OF CANCER

IPC classification:
A61K 31/357, A61K 31/47, A61P 35/00
Applicant:
Eisai R&D Management Co., Ltd.
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP14756108

METHOD

IPC classification:
C12Q 1/68
Applicant:
Oxford Nanopore Technologies Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION IN PROGRESS
EP14772216

METHOD

IPC classification:
G01N 33/68
Applicant:
Oxford University Innovation Ltd
Agent:
Multiple attorneys, J A Kemp
Status:
GRANT OF PATENT INTENDED
EP16150667

SHP-2 GENE MUTATIONS IN MELANOMA

IPC classification:
C07H 21/02, C07H 21/04, C07K 14/435, C12P 19/34, C12Q 1/68, G01N 33/53
Applicant:
University of California
Agent:
Multiple attorneys, J A Kemp
Status:
EXAMINATION REQUESTED

Please Sign in to use this feature